Read More Pharma Industry News Sanjivani Paranteral reports 58% growth in Q4 FY24 revenue at Rs 128.64 million Sanjivani Paranteral Ltd (BSE: 531569), a renowned pharmaceutical company based in Mumbai with manufacturing facilities in Navi Mumbai… byPallavi MadhirajuMay 13, 2024